Cubresa Announces the Appointment of 2 New Board Members
Tuesday, November 29th, 2022 PRESS RELEASE Cubresa Appoints Mr. Ryan Klassen and Ms. Trudy Martens to Board of Directors Winnipeg, MB – November 29th, 2022 – Cubresa Inc., a world leader in brain imaging, is announcing two 2 appointments to its board of directors, Mr. Ryan Klassen, and Ms. Trudy Martens. “The directors and I are…
Cubresa Appoints Ms. Leah Friesen as Director of Operations
Tuesday, April 5th, 2022 PRESS RELEASE Cubresa Appoints Ms. Leah Friesen as Director of Operations Winnipeg, MB – April 5th, 2022 – Cubresa Inc., a world leader in the design and development of PET insert systems for MRI, is announcing a new senior appointment within the company, Ms. Leah Friesen as the Director of Operations. “Cubresa’s…
Recognizing Dr. Sheryl Herrera
Cubresa is pleased to recognize the work of our colleague, Dr. Sheryl Herrera, who has been recently published in ScienceDirect – Axon diameter inferences in the human corpus callosum using oscillating gradient spin echo sequences – link here – https://www.sciencedirect.com/science/article/abs/pii/S0730725X21001818#ab0005 . University of Winnipeg article here – https://news.uwinnipeg.ca/researchers-develop-new-way-to-measure-human-brain/
Cubresa Appoints Mr. Jonathan Li as Vice President of Research and Development, and Ms. Lisa Bako as Vice President of Sales and Strategic Partnerships
Monday, October 25th, 2021 PRESS RELEASE Cubresa Appoints Mr. Jonathan Li as Vice President of Research and Development, and Ms. Lisa Bako as Vice President of Sales and Strategic Partnerships Winnipeg, MB – October 25th, 2021 – Cubresa Inc., a world leader in the design and development of PET insert systems for MRI, is announcing two…
DOTMed HealthCare magazine features Cubresa
Cubresa is pleased to have its clinical BrainPET insert system and preclinical NuPET Bio scanner, designed for use in infectious disease research, featured on page 34 in the June issue of DOTMed’s HealthCare Business News magazine. DOTMed HealthCare link The BrainPET is an investigational device and NOT AVAILABLE FOR COMMERCIAL SALE.
ISMRM 2021
Cubresa is pleased to be featuring its clinical BrainPET insert systems and its preclinical NuPET and NuPET Bio scanners at the ISMRM 2021 Annual Meeting and Exhibition. The virtual exhibition takes place from May 15th to 20th. We look forward to seeing you there!
Research Manitoba article features Cubresa
Research Manitoba features Cubresa’s NuPET Bio scanner in their latest Research Today publication. The new scanner is specifically designed for use in biosafety labs and will be used by scientists focused on SARS-CoV-2 research. Research Today Article
Research Manitoba COVID-19 Innovation Proof-of-Concept Grant Announcement
Cubresa is pleased to be the recipient of the Research Manitoba COVID-19 Innovation Proof-of-Concept Grant. For more information please go to the Research Manitoba website here. To read the press release from Research Manitoba in PDF format, click here.
UWinnipeg Magazine Article
Cubresa is proud to share UWinnipeg Magazine’s article, “Searching For a Cure”, featuring Cubresa System Scientist, Dr. Sheryl Herrera. Learn more about the important industry work Dr. Herrera is undertaking at Cubresa thanks to her supervisor, Dr. Melanie Martin, and the Mitacs Elevate postdoctoral fellowship. The article can be found on page 18. UWinnipeg Article
Cubresa is a world leader in the design and development of clinical and preclinical PET inserts for MRI. Cubresa products enable medical professionals at leading universities, hospitals and pharmaceutical companies to visualize and measure biochemical processes at the molecular level.
Company
About Us
Leadership
Technology
Careers
Location
Cubresa Inc.
800-136 Market Ave
Winnipeg, MB, Canada
R3B 0P4
Products
Clinical:
Preclinical:
Contact
Request more information